We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA to Defer Enforcing Violations Related to the Compounding of Radioactive Drugs
FDA to Defer Enforcing Violations Related to the Compounding of Radioactive Drugs
The FDA has laid out a list of situations in which the agency would not enforce certain violations related to the compounding and repackaging of radiopharmaceuticals.